5Weber L,Shipkova M,Lamersdorf T,Niedmann P,Wiesel M,Mandelbaum A,Zimmerhackl L,Schutz E,Mehls O,Oellerich M.Pharmacokinetics of mycophenolic acid(MPA)and determinants of MPA free fraction in pediatric and adult renal transplant recipients.German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.J Am.Soc.Nephrol,2005,9(8):1511-1520.
6杨霁云,白克敏.小儿肾脏病基础与临床.北京:人民卫生出版社,2004:238.
7Ozolins T R.Cyclophosphamide and the Teratology Society:an awkward marriage.Birth Defects Res B Dev Reprod.Toxicol,2011,89(4):289-299.
8Hu R Q,Mehter H,Nadasdy T,Satoskar A,Spetie D N,Rovin B H,Hebert L.Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy:case report and literature review.Rheumatol Int,2008,28(11):1161-1164.
9Faedda R,Pirisi M,Satta A,Bosincu L,Bartoli E.Regression of Henoch-Schonlein disease with intensive immunosuppressive treatment.Clin Pharmacol Ther,2006,60(5):576-581.
10Fukudome K,Fujimoto S,Sato Y,et al.Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults[J].Nephrology,2012,17(3):263-268.
